Conclusions The main differences reside in the better prognosis of the patients with MAS and the lesser proportion associated with severe illness (p<0.005). The presence of autoimmune disease seems to act as a trigger factor per se, and the infection does not appear to play an important role ...
less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis terms of quality of life (QL), tumour response and survival in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor ... NM Bleehen,...
He unfortunately died after 20days because of disseminated intravascular coagulation (DIC). For the first time, we described a child with COVID-19-related HLH and severe cardiac failure, which had a poor prognosis despite a heart transplant.doi:10.1002/ehf2.13728Mohammad Mahdavi...
Hemophagocytic lymphohistiocytosis (HLH) has had a dismal prognosis; in 1983, long-term survival was reported as 4%.1 Since then, and with the introduction of an international treatment collaboration, survival has increased dramatically worldwide.2,3 We present a summary of the long-term outcome ...
This is extremely important for life-saving and get- ting improved prognosis by giving patients appropriate treat- ment as soon as possible. In order to prevent misdiagnosis and give as much information as possible for clinicians, it will be helpful and necessary to do this genetic analysis ...
基因名 检测数据 检测结果 变异比例 临床意义 ALK ALK:NM_004304:exon5:c.G1229T:p.G410V 三级变异...
HLH-2004 方案.pdf,Histiocyte Society HLH-2004 Hemophagocytic Lymphohistiocytosis Study Group Treatment Protocol of the Second International HLH Study 2004 Start of the Study: January 2004 Chairman: Jan-Inge Henter, M.D., Ph.D., Stockholm, Sweden HLH-2004